People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Pharmaceuticals, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intra Cellular Therapies Inc | — | Pharmaceuticals | Series C | $80.9M | $2.1B | 2013 |
| Gliknik Inc | — | Biotechnology | Series A | $50.7M | $33.6M | 2023 |
| HHC Senior Housing Fund I, LLC | — | Other Health Care | Series A | $10.2M | $205.9M | 2013 |
| Cognos Therapeutics Inc | — | Biotechnology | Series C | $7.7M | $44.2M | 2018 |
| Alavita Pharmaceuticals Inc | — | Biotechnology | Pre-Seed | $600K | $33.1M | 2009 |
Richard Lerner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Lerner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joel Marcus | 1 | 9 |
| Gordon Ringold | 1 | 7 |
| Eli Gang | 1 | 5 |
| Josh Shachar | 1 | 5 |
| Frank Adell | 1 | 5 |
| Thomas Chen | 1 | 5 |
| Richard S. Levy | 1 | 4 |
| John Peterson | 1 | 4 |
| Raymond F. Schinazi | 1 | 4 |
| Richard Levy | 1 | 4 |
| Ronald Solar | 1 | 3 |
| David Broser | 1 | 3 |
| Sharon Mates | 1 | 2 |
| Roger Kornberg, Ph.D. | 1 | 2 |
| Raymond S. Schinazi | 1 | 2 |
| Charles Polsky | 1 | 2 |
| Paul A. Friedman | 1 | 2 |
| Sam Colella | 1 | 2 |
| David S. Block | 1 | 2 |
| Winston Wu | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.